9 Apr 2018 | Business Insider
Federal policies restricting marijuana research have made it difficult to study marijuana and produce cannabis-based drugs - but that isn't stopping pharmaceutical companies from doing it.
26 Mar 2018 | Philly.com
The medical cannabis program in Pennsylvania is about to enter unprecedented territory as it embarks on the nation’s first state-sanctioned research program.
23 Mar 2018 | Leafly
Trying to keep track of all the advances in medical cannabis research? Here are some brief summaries of some of the biggest headlines over the last few months
17 Mar 2018 | mg Cannabis Retailer
The European Journal of Internal Medicine (EJIM) has published a special issue for March titled "Cannabis in Medicine."
16 Mar 2018 | Huntington's Disease News
MMJ BioScience has been licensed in Canada to produce cannabis-derived medicines for testing in FDA-approved studies for Huntington’s disease.
13 Mar 2018 | Neurology Advisor
Cannabinoids are effective as an adjunctive treatment for reducing seizure frequency in pediatric-onset treatment-resistant epilepsy.
8 Mar 2018 | European Pharmaceutical Review
Naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures,
6 Mar 2018 | Proactiveinvestors
Treatment with cannabinoid-based extracts could be an alternative to chemotherapy
27 Feb 2018 | Leafly
Dosage is the key factor in achieving the most benefits and least adverse effects of cannabis
22 Feb 2018 | Pharma Times
A mid-stage trial assessing an experimental cannabinoid being developed by GW Pharma for adults with focal seizures has failed to hit key targets.